,
Document Type : Research Paper
Abstract
Background: Acne vulgaris is a common skin conditions; about 74% of patients with acne have moderate to severe effect on their quality of life. Acne management aims to alleviate symptoms, clear existing lesions, limit disease activity by preventing new lesions forming and scars developing and avoid negative impact on quality of life.
Objective: To evaluate the effectiveness of both Clindamycin and Ciprofloxacin solutions topically in the treatment of mild to moderate acne vulgaris.
Method: A single blinded therapeutic trial that was conducted at Baghdad Teaching Hospital/ department of dermatology, out clinic, for the period (April 2019 - March 2020). All patients with mild - moderate acne vulgaris attended to the out clinic of dermatology were enrolled in the study. Sixty six patients were participated in this study and divided in to 2 groups (Ciprofloxacin group: 33 patients were treated topically with Ciprofloxacin solution 2% and Clindamycin group: 33 patients were treated topically with Clindamycin solution 1.5%). The important ethical approval and formal consent was obtained from MOH and patients respectively. Severity index was recorded. Statistical analysis was done using SPSS V26.
Results: Mean acne severity index (ASI) for Ciprofloxacin group in the first visit was significantly higher than that at week 12th after topical application of Ciprofloxacin. Total percent reduction was 32.3% (P<0.001). Mean ASI for Clindamycin group in the first visit was significantly higher than that at week 12th after topical application of Finasteride. Total percent reduction was 31.8% (P<0.001). No statistical significant among both groups regarding the reduction in comedones mean; P>0.05. Statistical significant was observed among Ciprofloxacin group regarding the reduction of papules and pustules in comparison to Clindamycin group; P<0.05
Conclusion: Ciprofloxacin and clindamycin when used topically are all effective in treatment of mild to moderate acne vulgaris. Both have antibacterial and anti-inflammatory actions
Keywords
-
Ciprofloxacin solution,,
-
,،Clindamycin Solution,,
-
,،Topical Treatment,,
-
,،Acne Vulgaris,,
-
,،Acne Severity Index
- Al-Hamamy HR, Abood SY. Quality of Life Assessment in Iraqi Patients with Acne Vulgaris and Psoriasis. Iraqi Academic Scientific Journal. 2017;16:345-48.
- Layton AM, Eady EA, Zouboulis CC, Acne. In: Rook's Textbook of Dermatology, Griffiths C, Barker J, Bleiker TO, Chalmers R, Creamer D. 9th, Jhon Wiley & Sons Ltd., 2016;3:90:1-65.
- Goh C, Cheng C, Agak G, Zaenglein AL, Graber EM, Thiboutot DM, Kim J. Acneiform Disorders. In: Fitzpatrick’s Dermatology, Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS. 9th McGraw-Hill Education, 2019;1:78:1391-1418.
- Alwan NK, Shakir SA, Waheeb HH. Epidemiology of skin diseases among displaced people in Diyala Province. Journal of the Faculty of Medicine Baghdad. 2018 ;60:52-56.
- Fadheel BM. Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients. Journal of the Faculty of Medicine Baghdad. 2013 ;55:53-55.
- Zouboulis CC. Is acne vulgaris a genuine inflammatory disease?. Dermatology. 2001;203:277-79.
- Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. The Journal of Immunology. 2002;169:1535-41.
- Douri F. Clinical and microbiological study of acne lesions in Iraqi patients. A thesis submitted to the College of Medicine University of Baghdad for the degree of Master of Science in Medical Microbiology 1997.
- Layton AM, Eady EA, Zouboulis CC, Acne. In: Rook's Textbook of Dermatology, Griffiths C, Barker J, Bleiker TO, Chalmers R, Creamer D. 9th, Jhon Wiley & Sons Ltd., 2016;3:90:1-65.
- Gauthier TP, Unger NR. Quinolones, Folic Acid Antagonists and Urinary Tract Antiseptics. In: Lippincott’s Illustrated Reviews: Pharmacology, Whalen K, Finkel R, Panavelil TA. 6th, Wolters Kluwer, 2015; 40:513-524.
- Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology. 2003;49:S1-37.
- Zaenglein AL, Thiboutot DM. Acne Vulgaris. In: Dermatology, Bolognia JL, Schaffer JV, Cerroni L. 4th Elsevier, 2018;36:588-603.
- Sam R, Ives HE, Pearce D. Diuretic Agents; Beauduy CE, Winston LG. Sulfonamides, Trimethoprim & Quinolones. In: Basic and Clinical Pharmacology, Katzung BG. 14th, McGraw-Hill Education, 2018; 15: 254-275; 46:834-41.
- Gauthier TP, Unger NR. Quinolones, Folic Acid Antagonists and Urinary Tract Antiseptics. In: Lippincott’s Illustrated Reviews: Pharmacology, Whalen K, Finkel R, Panavelil TA. 6th ed., Wolters Kluwer, 2015; 40:513-24.
- Prajna NV, George C, Selvaraj S, Lu KL, McDonnell PJ, Srinivasan M. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis. Cornea. 2001;20:175-78.
- Mösges R, Nematian-Samani M, Eichel A. Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution. Therapeutics and Clinical Risk Management. 2011;7:325.
- Hamilton AR, Hutcheon GA, Roberts M, Gaskell EE. Formulation and antibacterial profiles of clay–ciprofloxacin composites. Applied Clay Science. 2014;87:129-35.
- Al-Ethawi A. Ciprofloxacin 1% gel in the treatment of mild to moderate acne vulgaris. A thesis submitted to the Iraqi Board for Medical Specialization. Dermatology and Venereology 2006.
- Al-Jabory DM. Treatment of acne vulgaris, mild acne using topical ciprofloxacin solution 1.5% versus topical clindamycin solution 1.5%, moderate acne by topical ciprofloxacin solution 1.5% and oral ciprofloxacin versus topical clindamycin solution 1.5% and oral doxycycline. A thesis submitted to Scientific Council of Dermatology and Venereology, Iraqi Board for Medical Specializations, 2012.
- Adityan B, Kumari R, Thappa DM. Scoring systems in acne vulgaris. Indian Journal of Dermatology, Venereology, and Leprology. 2009;75:323.
- Habif TP. Acne, Rosacea and Related Disorders. In: Clinical Dermatology, A Color Guide to Diagnosis and Therapy. 6th, Elsevier Inc., 2016;7: 218-62.
- Vali A, Faghihi G, Zaghian N, Koosha M. The efficacy of topical solution of 0.3% ciprofloxacin in treatment of mild to moderate acne vulgaris. Iranian Red Crescent Medical Journal. 2009;11:23-27.
- Tunca M, Akar A, Ozmen I, Erbil H. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne. International Journal of Dermatology. 2010;49:1440-44.
- Zhang JZ, Li LF, Tu YT, Zheng J. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. Journal of Dermatological Treatment. 2004 ;15:372-78.
- Alirezai M, Gerlach B, Horvath A, Forsea D, Briantais P, Guyomar M. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris. European Journal of Dermatology. 2005;15:274-78.
- Guay DR. Topical clindamycin in the management of acne vulgaris. Expert opinion on pharmacotherapy. 2007;8:2625-64.
- Vali A, Faghihi G, Zaghian N, Koosha M. The Efficacy of Topical Solution of 0.3% Ciprofloxacin in Treatment of Mild to Moderate Acne Vulgaris. IRCMJ 2009;11:23-27.
- Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002 ;24:1117-33.
)
